Futurechem Co Ltd (220100)

Currency in KRW
20,500
+2,160(+11.78%)
Delayed Data·
Unusual trading volume
220100 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
20,17522,900
52 wk Range
14,90035,050
Key Statistics
Bid/Ask
20,450.00 / 20,500.00
Prev. Close
18,340
Open
22,600
Day's Range
20,175-22,900
52 wk Range
14,900-35,050
Volume
441.44K
Average Volume (3m)
134.58K
1-Year Change
12.0928%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
220100 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Life Sciences Tools & Services industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Mar 06, 2026
EPS / Forecast
-339.45 / --
Revenue / Forecast
6.16B / --
EPS Revisions
Last 90 days

220100 Income Statement

Compare 220100 to Peers and Sector

Metrics to compare
220100
Peers
Sector
Relationship
P/E Ratio
−36.5x7.1x−0.5x
PEG Ratio
1.900.040.00
Price/Book
7.5x1.5x2.6x
Price / LTM Sales
22.0x3.0x3.3x
Upside (Analyst Target)
-53.3%47.7%
Fair Value Upside
Unlock−14.6%6.6%Unlock

FutureChem Co.,Ltd engages in the research and development, production, and sale of chemicals, pharmaceuticals, and medical devices in South Korea and internationally. The company offers radioactive pharmaceuticals, including [18F]FDG for the treatment of general cancer diagnosis, PDvue for Parkinson's disease, Alzavue for Alzheimer's disease, and FLT for the lung cancer diagnosis. Its products in pipeline include [18F]FC303, [177Lu]FC705, and 225Ac for the treatment of prostate cancer; F-FMT for brain tumor diagnosis; FC-505 for the treatment of arteriosclerosis and myocardial infarction; FC-211 for Alzheimer's disease; FC-2 for the treatment of hypoxia; FC-3 for solid cancer; FC801 for bladder cancer; and FC901 for the treatment of pulmonary fibrosis. The company also provides automatic synthesis equipment, such as sCUBE-RXN (synthetic), sCUBE-P&F (tablet-formulation), and sCUBE-M (radioactive, metal). In addition, it offers molecular imaging device airway sleeve and disposable cartridges, as well as engages in medical device wholesale and healthcare business. FutureChem Co.,Ltd was founded in 1999 and is headquartered in Seoul, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
10.78K0.05%197.61M
Other Institutional Investors
0.000.00%0.00
Public Companies & Retail Investors
22.41M99.95%410.98B
Total
22.42M100.00%411.18B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
SPDR Index Shares Funds - State Street SPDR S&P International Small Cap ETF0.05%10,775197,614

People Also Watch

314,000
062040
+18.05%
340,000
214450
+8.45%
63,300
290650
+0.16%
89,900
375500
-9.19%
59,800
397030
+0.84%

FAQ

What Is the Futurechem (220100) Stock Price Today?

The Futurechem stock price today is 20,500 KRW.

What Stock Exchange Does Futurechem Trade On?

Futurechem is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Futurechem?

The stock symbol for Futurechem is "220100."

What Is the Futurechem Market Cap?

As of today, Futurechem market cap is 411.22B KRW.

What Is Futurechem's Earnings Per Share (TTM)?

The Futurechem EPS (TTM) is -508.

From a Technical Analysis Perspective, Is 220100 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Futurechem Stock Split?

Futurechem has split 3 times.

What is the current trading status of Futurechem (220100)?

As of May 04, 2026, Futurechem (220100) is trading at a price of 20,500 KRW, with a previous close of 18,340 KRW. The stock has fluctuated within a day range of 20,175 KRW to 22,900 KRW, while its 52-week range spans from 14,900 KRW to 35,050 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.